Literature DB >> 2031288

How does p21ras transform cells?

C J Marshall1.   

Abstract

Oncogenic forms of p21ras are found in a wide range of human tumors. However, the mechanism by which p21ras transforms remains obscure. Genetic evidence has identified a domain of p21ras that is involved with interaction with an effector molecule required for transformation. Two proteins, GAP and the tumor suppressor NF1, interact with p21ras in this region but it is an unresolved puzzle whether either of these is the an unresolved puzzle whether either of these is the effector. After interaction with an effector, two downstream events--activation of protein kinase C and another pathway--are necessary for induction of DNA synthesis by oncogenic p21ras; however, morphological transformation does not require activation of protein kinase C.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2031288     DOI: 10.1016/0168-9525(91)90278-X

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  16 in total

Review 1.  Gene therapy in lung cancer.

Authors:  S G Swisher; J A Roth
Journal:  Curr Oncol Rep       Date:  2000-01       Impact factor: 5.075

2.  Functional role of GTPase-activating protein in cell transformation by pp60v-src.

Authors:  J E DeClue; W C Vass; M R Johnson; D W Stacey; D R Lowy
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

3.  Upstream CREs participate in the basal activity of minute virus of mice promoter P4 and in its stimulation in ras-transformed cells.

Authors:  M Perros; L Deleu; J M Vanacker; Z Kherrouche; N Spruyt; S Faisst; J Rommelaere
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

4.  Cell transformation by c-fos requires an extended period of expression and is independent of the cell cycle.

Authors:  G G Miao; T Curran
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

Review 5.  Clinical relevance of KRAS in human cancers.

Authors:  Sylwia Jancík; Jirí Drábek; Danuta Radzioch; Marián Hajdúch
Journal:  J Biomed Biotechnol       Date:  2010-06-07

6.  p21ras and protein kinase C function in distinct and interdependent signaling pathways in C3H 10T1/2 fibroblasts.

Authors:  A Krook; M J Rapoport; S Anderson; H Pross; Y C Zhou; D T Denhardt; T L Delovitch; T Haliotis
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

7.  The bovine papillomavirus E5 oncogene can cooperate with ras: identification of p21 amino acids critical for transformation by c-rasH but not v-rasH.

Authors:  B M Willumsen; W C Vass; T J Velu; A G Papageorge; J T Schiller; D R Lowy
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

8.  A 34-kd protein with strong homology to ras-like proteins inhibits epidermal growth factor activity.

Authors:  D S Strayer; J Mathew
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

9.  Identification and characterization of the neurofibromatosis type 1 protein product.

Authors:  J E DeClue; B D Cohen; D R Lowy
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

10.  Kinetic selectivity of cholinephosphotransferase in mouse liver: the Km for CDP-choline depends on diacylglycerol structure.

Authors:  C R Mantel; A R Schulz; K Miyazawa; H E Broxmeyer
Journal:  Biochem J       Date:  1993-02-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.